Literature DB >> 28940224

Therapy access among children with autism spectrum disorder, cerebral palsy, and attention-deficit-hyperactivity disorder: a population-based study.

Teal W Benevides1, Henry J Carretta2, Carole K Ivey3, Shelly J Lane4.   

Abstract

AIM: This study examined cross-sectional population-based rates in reported need and unmet need for occupational, physical, and speech therapy services in children with autism spectrum disorder (ASD) compared with children with attention-deficit-hyperactivity disorder (ADHD) and cerebral palsy (CP).
METHOD: The 2005-2006 and 2009-2010 (USA) National Survey of Children with Special Health Care data sets were used to compare therapy need and unmet need among children younger than 18 years with ASD (n=5178), ADHD (n=20 566), and CP (n=1183). Bivariate approaches and multivariate logistic regression using imputed data were used to identify associations between child and family characteristics, and access to therapy services.
RESULTS: After adjusting for other variables, children with ASD had a significantly greater likelihood of having an unmet therapy need compared with children with ADHD (odds ratio [OR] 1.66, 95% confidence interval [CI] 1.36-2.03), but a similar unmet need as children with CP (OR 1.30, 95% CI 0.97-1.74). Factors associated with unmet need included survey year, younger child age, no health insurance, and increased functional and behavioral difficulties.
INTERPRETATION: Children in our sample had greater unmet therapy needs in 2009 than in 2005. Caregiver-reported reasons for unmet need included cost and school resources. Research examining future trends in therapy access are warranted for children with ASD and CP. WHAT THIS PAPER ADDS: Children with complex diagnoses of autism spectrum disorder and cerebral palsy had reported unmet need for therapy services. High costs of therapy were the primary reported reason contributing to reduced access among children.
© 2017 Mac Keith Press.

Entities:  

Mesh:

Year:  2017        PMID: 28940224     DOI: 10.1111/dmcn.13560

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  7 in total

1.  Shared Features or Co-occurrence? Evaluating Symptoms of Developmental Coordination Disorder in Children and Adolescents with Autism Spectrum Disorder.

Authors:  Haylie L Miller; Gabriela M Sherrod; Joyce E Mauk; Nicholas E Fears; Linda S Hynan; Priscila M Tamplain
Journal:  J Autism Dev Disord       Date:  2021-01-02

Review 2.  Systematic Review: United States Workforce for Autism-Related Child Healthcare Services.

Authors:  Ryan K McBain; Vishnupriya Kareddy; Jonathan H Cantor; Bradley D Stein; Hao Yu
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2019-05-29       Impact factor: 8.829

3.  Is the Autism Boom Headed for Medicaid? Patterns in the Enrollment of Autistic Adults in Wisconsin Medicaid, 2008-2018.

Authors:  Eric Rubenstein; Lauren Bishop
Journal:  Autism Res       Date:  2019-07-17       Impact factor: 5.216

4.  Therapy use for U.S. school-aged children with developmental disabilities: State variation and determinants.

Authors:  Olivia Lindly; Megan C Eaves; Yue Xu; Chelsey L Tarazi; Sowmya R Rao; Karen A Kuhlthau
Journal:  Disabil Health J       Date:  2021-08-28       Impact factor: 2.554

5.  Community-based service use in preschool children with autism spectrum disorder and associations with insurance status.

Authors:  Eric Rubenstein; Lisa Croen; Li-Ching Lee; Eric Moody; Laura A Schieve; Gnakub N Soke; Kathleen Thomas; Lisa Wiggins; Julie Daniels
Journal:  Res Autism Spectr Disord       Date:  2019-06-15

6.  Patterns of Health Service Use Among Young People With Cerebral Palsy in England.

Authors:  Jennifer M Ryan; Grace Lavelle; Nicola Theis; Cherry Kilbride; Marika Noorkoiv
Journal:  Front Neurol       Date:  2021-05-12       Impact factor: 4.003

Review 7.  Autism Spectrum Disorders and ADHD: Overlapping Phenomenology, Diagnostic Issues, and Treatment Considerations.

Authors:  Kevin M Antshel; Natalie Russo
Journal:  Curr Psychiatry Rep       Date:  2019-03-22       Impact factor: 8.081

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.